Mode
Text Size
Log in / Sign up

Bifidobacterium longum BB536 shows no significant effect on GI symptoms in athletes on high-protein dietAthletes on high protein diets see gut and odor changes with probiotic

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that Bifidobacterium longum BB536 did not significantly improve overall GI symptoms in athletes on a high-protein diet.

This exploratory randomized controlled trial enrolled 60 healthy male athletes with a mean age of 18.62 years and mean BMI of 22.35 kg/m². Participants received Bifidobacterium longum BB536 (46 billion CFU/day) plus a whey protein supplement (70 g/day) or a placebo plus the same whey protein supplement for 4 weeks.

The primary outcome was not reported. In the overall cohort, no significant between-group differences were observed for gastrointestinal outcomes, gut microbiota indices, or metabolite profiles. Within the BB536 group, diarrhea-related scores improved from baseline. In a Bacteroides-dominant microbiota subgroup, skin-emitted short-chain fatty acids were higher after BB536 intake. In a Prevotella-dominant subgroup, odor-related metabolites (methyl mercaptan and ammonia) showed reductions. Fecal metabolite shifts in subgroup analyses were modest.

Safety and tolerability were not reported. Key limitations include the exploratory post hoc nature of subgroup analyses, a small sample size for subgroups, a short 4-week follow-up, and the lack of significant overall results. Practice relevance is limited; findings are exploratory and hypothesis-generating, requiring confirmatory trials with prespecified endpoints. Causation is not established, and certainty is low.

Many athletes load up on protein to build muscle and boost performance. But a high protein diet can sometimes upset the gut. It can cause bloating, gas, or loose stools. It can also lead to body odor that is hard to control. Now, a new study suggests a probiotic called BB536 may help. It eased gut symptoms and odor in some athletes. The key is the type of bacteria already living in the gut.

High protein diets are common in sports. Whey protein shakes are easy and popular. They can help with recovery and strength. But they can also change the gut environment. These diets may shift the balance of gut bacteria. They may increase certain compounds that cause odor. Athletes often notice more gas or stomach upset. They may also notice changes in skin or breath odor. Current solutions include fiber, hydration, and probiotics. But results can vary a lot from person to person.

Here is the twist. The new study found that BB536 did not help every athlete. It worked best in specific subgroups. These subgroups were defined by their baseline gut bacteria. This suggests that one size does not fit all. It also suggests that testing gut bacteria could guide probiotic use in the future.

Think of the gut as a garden. The bacteria are the plants. Some plants are helpful. Others can cause trouble. A high protein diet can change the soil. It can favor certain plants over others. A probiotic is like adding new seeds. But the new seeds only grow well if the soil is right. BB536 is a strain of Bifidobacterium longum. It is a friendly bacterium. It may help restore balance in the right soil.

The study included 60 healthy male athletes. Their average age was about 19 years. They took a whey protein supplement each day. They also took either BB536 or a placebo for four weeks. The trial was double blind. That means neither the athletes nor the researchers knew who got the probiotic. The researchers measured gut symptoms, gut bacteria, and odor related compounds. They also looked at fecal metabolites.

In the full group, there were no major differences between BB536 and placebo. Overall gut symptoms were similar. Gut bacteria patterns did not change much. Odor related compounds were also similar. But within the BB536 group, diarrhea related scores improved from baseline. This means some athletes felt better over time.

This does not mean BB536 is a cure for gut issues.

Post hoc analyses suggested that responders had specific changes in gut bacteria. Enterotype based patterns also emerged. Athletes with a Bacteroides dominant microbiota showed higher skin emitted short chain fatty acids after BB536. Those with a Prevotella dominant microbiota had reductions in odor related metabolites. These included methyl mercaptan and ammonia. Fecal metabolite shifts were modest. This means the changes were small but detectable in specific groups.

An expert perspective is important here. The authors note that these findings are exploratory. They did not extend to the full cohort. This means the results are hypothesis generating. They suggest that baseline gut bacteria may influence probiotic response. Confirmatory trials with prespecified endpoints are needed. This is a careful and responsible approach.

What does this mean for you? If you are an athlete on a high protein diet, talk to your doctor or a sports dietitian. They can help you manage gut symptoms and odor. They may suggest fiber, hydration, or probiotics. BB536 is available in some supplements. But it may not work for everyone. Testing gut bacteria is not routine yet. It may become more common in the future.

The study has limitations. It was small and short. It only included young male athletes. It did not include women or older adults. The findings are early and need replication. The probiotic dose was high, at 46 billion CFU per day. This may not be typical for all products.

What happens next? Larger trials are needed to confirm these findings. Researchers should prespecify subgroups based on gut bacteria. They should also look at longer term effects. If results hold, BB536 could be tailored to athletes with specific gut patterns. This would be a step toward personalized nutrition. For now, the study adds to evidence that gut bacteria matter for diet and health.

Study Details

Study typeRct
EvidenceLevel 2
Follow-up9.0 mo
PublishedDec 2026
View Original Abstract ↓
BACKGROUND: High‑protein diets are widely used by athletes but may disturb the gut environment and increase production of odor‑related metabolites. Probiotic supplementation has been proposed as a strategy to support gastrointestinal function under such dietary stress. This study aimed to explore the effects of BB536 on gastrointestinal symptoms, gut microbiota, and odor‑related metabolites in male athletes consuming a high‑protein diet. METHODS: In an exploratory, randomized, double‑blind, placebo‑controlled trial, 60 healthy male athletes (mean age: 18.62 ± 0.75 years; mean BMI: 22.35 ± 1.80 kg/m) consumed a whey protein supplement (70 g/day) together with either BB536 (46 billion CFU/day, as measured at the start of the intervention) or placebo for 4 weeks. Gastrointestinal symptoms, gut microbiota composition, skin‑emitted volatile compounds, and fecal metabolites were assessed. Subgroup analyses based on responder status and baseline enterotype were conducted post hoc to generate hypotheses regarding microbiota‑dependent responses. RESULTS: In the overall cohort, no significant between‑group differences were observed across gastrointestinal outcomes, gut microbiota indices, or metabolite profiles. Within the BB536 group, diarrhea‑related scores improved from baseline. Post hoc analyses suggested that increases in were evident among responders. Enterotype‑based patterns also emerged: individuals with ‑dominant microbiota showed higher skin‑emitted short‑chain fatty acids after BB536 intake, whereas those with ‑dominant microbiota exhibited reductions in odor‑related metabolites, including methyl mercaptan and ammonia. Corresponding fecal metabolite shifts were modest. CONCLUSION: BB536 supplementation was associated with improvements in diarrhea‑related symptoms and odor‑related metabolites in specific microbiota‑defined subgroups. As these findings did not extend to the full cohort, they should be interpreted as exploratory and hypothesis‑generating. Baseline gut microbiota composition may influence probiotic responsiveness, warranting confirmatory trials with prespecified endpoints.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.